To embed, copy and paste the code into your website or blog:
For several years, China has been evaluating changes to its drug approval system to promote drug innovation and patient access to medicines. The year 2020 saw China begin taking steps towards adopting some of those changes. U.S. biopharma companies doing business in China, and those looking to do business in China, should start preparing now for the changes coming in 2021.
I. Economic and Trade Agreement Between the United States of America and the People’s Republic of China (Phase One) signed January 15, 2020 (the “Phase One Trade Agreement”)
The year 2020 began with China formally committing, in the Phase One Trade Agreement signed with the United States on January 15
Monday, December 21, 2020
On December 21, 2020, the Beijing Intellectual Property Court announced that on December 18, 2020, the Court ruled in several administrative trademark cases that the trademark registrants forged evidence to prove use in trademark cancellation proceedings. The registrants had provided fake tax invoices to prove use via the sales. However, the tax invoices didn’t match queries with the National Value-Added Tax Invoice Inspection Platform of the State Administration of Taxation. Accordingly, the Court reversed the earlier rulings based on the forged evidence and fined the registrants.
There was a total of eight administrative litigations.
The plaintiff Dongguan Jinji Environmental Technology Co., Ltd. (东莞市金基环保科技有限公司) sued the China National Intellectual Property Administration (CNIPA) and the third party (trademark registrant) Jilin Province Green Forest Environmental Protection Technology Co., Ltd. (吉林�
Print
TOKYO Bridgestone Corp. is claiming victory in a patent infringement lawsuit in China against Chinese tire manufacturer Shandong Vheal Group Co. Ltd.
The lawsuit, which was filed in September 2017, involved patent rights protecting Bridgestone s R118 truck tire tread pattern, which was developed by the group for China and other Asian markets, the tire maker said.
Bridgestone claimed in its suit with the Beijing Intellectual Property Court that Shandong Vheal manufactured and sold truck tires utilizing a tread pattern that was covered under a Bridgestone patent.
In June 2020, Bridgestone said, the Beijing court upheld its claim and ordered Shandong Vheal to cease activities that are in violation of the group s patent rights and to pay approximately $76,500 in damages to Bridgestone. The court issued its decision in October 2020.
Bridgestone claims tire tread patent infringement lawsuit win in China tirebusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tirebusiness.com Daily Mail and Mail on Sunday newspapers.